Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2026-01-01 @ 1:35 PM
Study NCT ID:
NCT01479595
Status:
COMPLETED
Last Update Posted:
2016-08-01
First Post:
2011-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Study Overview
Official Title:
A Randomized Double-blind Multiple-dose Placebo-controlled Trial to Establish the Efficacy of QBX258 (Combination of VAK694 and QAX576) in Asthma That is Inadequately Controlled With Inhaled Corticosteroids and Long Acting Beta Agonists
Status:
COMPLETED
Status Verified Date:
2016-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to investigate the efficacy and safety of QBX258 in subjects with moderate to severe asthma.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2011-003066-32 | EUDRACT_NUMBER | None | View |